The Journal of cardiovascular surgery · 2018
What are the remaining limitations of TAVI?
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
De Biase Chiara, Mastrokostopoulos Antonios, Philippart Raphael, Bonfils Laurent, Berthoumieu Pierre, Dumonteil Nicolas
Аннотация
Transcatheter aortic valve implantation (TAVI) is a recognized therapy for patients with symptomatic severe aortic stenosis (AS). TAVI is superior compared to medical therapy as for mortality in extreme-risk patients, is non-inferior or superior to surgery in high-risk patients and non-inferior to surgery in intermediate-risk patients. However, several limitations affect outcomes after TAVI. Adverse events related to this procedure, like vascular complications, need for pacemaker implantation, paravalvular regurgitation, can be factors limiting TAVI treatment in younger patients at lower risk, as well as uncertainties regarding valve durability. This review tries to figure out some of the main complications still unsolved after TAVI.
Предметные рубрики MeSH
Aortic ValveAortic Valve InsufficiencyAortic Valve StenosisArrhythmias, CardiacCardiac Pacing, ArtificialFibrinolytic AgentsHeart Valve ProsthesisHumansPacemaker, ArtificialPostoperative ComplicationsProsthesis DesignProsthesis FailureRisk FactorsSeverity of Illness IndexStrokeThrombosisTranscatheter Aortic Valve ReplacementTreatment OutcomeVascular Diseases